Jeffrey P Harris Selected Research

Antigens

12/2007	AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis.
1/2005	Innate immunity contributes to cochlear adaptive immune responses.
1/2005	Cochlear microperfusion: experimental evaluation of a potential new therapy for severe hearing loss caused by inflammation.
9/2002	Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey P Harris Research Topics

Disease

10	Hearing Loss (Hearing Impairment) 01/2017 - 01/2002
6	Inflammation (Inflammations) 01/2017 - 09/2002
6	Sensorineural Hearing Loss 01/2017 - 10/2003
3	Vertigo (Positional Vertigo) 02/2019 - 07/2004
3	Tinnitus 02/2019 - 01/2013
3	Neoplasms (Cancer) 12/2018 - 01/2011
3	Labyrinthitis (Otitis Interna) 12/2007 - 01/2003
2	Labyrinth Diseases 06/2009 - 10/2003
2	Meniere Disease (Menieres Disease) 07/2004 - 03/2002
1	Otosclerosis 01/2020
1	Disease Progression 12/2018
1	Plasma Cell Granuloma 12/2018
1	Headache (Headaches) 01/2017
1	Hallucinations (Hallucination) 01/2017
1	Neurosarcoidosis 01/2017
1	Ataxia (Dyssynergia) 01/2017
1	Paralysis (Palsy) 01/2017
1	Diplopia (Double Vision) 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Exostoses 04/2011
1	Carcinoma (Carcinomatosis) 01/2011
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2011
1	Sarcoma (Soft Tissue Sarcoma) 01/2011
1	Otitis Externa 12/2010
1	Weight Gain 06/2009
1	Hyperglycemia 06/2009
1	Deafness (Deaf Mutism) 01/2009
1	Susac Syndrome 01/2009
1	Hypersensitivity (Allergy) 08/2007
1	Otitis Media 12/2006
1	Cochlear Diseases 09/2002
1	Wounds and Injuries (Trauma) 09/2002
1	Fibrosis (Cirrhosis) 09/2002

Drug/Important Bio-Agent (IBA)

6	SteroidsIBA 02/2019 - 09/2005
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 10/2003
4	AntigensIBA 12/2007 - 09/2002
2	Rituximab (Mabthera)FDA Link 12/2018 - 01/2013
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 10/2003
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2016 - 09/2015
2	Prednisone (Sone)FDA LinkGeneric 05/2011 - 06/2009
2	Methylprednisolone FDA LinkGeneric 05/2011 - 01/2009
2	CytokinesIBA 06/2003 - 09/2002
2	Etanercept (Enbrel)FDA Link 01/2003 - 09/2002
1	Biological ProductsIBA 02/2019
1	Opioid Analgesics (Opioids)IBA 12/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	AntibodiesIBA 01/2015
1	Adalimumab (Humira)FDA Link 01/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2011
1	Imatinib Mesylate (Gleevec)FDA Link 01/2011
1	Formaldehyde (Formol)FDA Link 01/2011
1	Phosphotransferases (Kinase)IBA 01/2011
1	Tyrosine (L-Tyrosine)FDA Link 01/2011
1	Hyaluronic Acid (Hyaluronan)IBA 12/2007
1	JNK Mitogen-Activated Protein KinasesIBA 12/2007
1	D-JNKI-1IBA 12/2007
1	NickelIBA 08/2007
1	Phosphates (Orthophosphate)IBA 01/2005
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2004
1	Dihydrotachysterol (AT 10)IBA 10/2003
1	Pharmaceutical PreparationsIBA 01/2003
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2003
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 09/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002

Therapy/Procedure

9	Therapeutics 12/2018 - 01/2002
4	Aftercare (After-Treatment) 05/2011 - 01/2003
2	Mastoidectomy 12/2018 - 12/2006
2	Injections 01/2009 - 07/2004
1	Hearing Aids (Hearing Aid) 01/2020
1	Stapes Surgery (Stapedectomy) 01/2020
1	Cochlear Implantation 01/2017
1	Craniotomy 04/2011
1	Skin Transplantation (Skin Grafting) 12/2010
1	Debridement 12/2010
1	Prostheses and Implants (Prosthesis) 08/2007
1	Retreatment 07/2004